416P Prognostic impact of liquid biopsy (LB) biomarkers at relapse on second-line (2L) treatment (Tx) after progression to endocrine therapy (ET) in metastatic breast cancer (mBC): Ancillary analysis of the MAGNETIC.1 study.
Saved in:
| Title: | 416P Prognostic impact of liquid biopsy (LB) biomarkers at relapse on second-line (2L) treatment (Tx) after progression to endocrine therapy (ET) in metastatic breast cancer (mBC): Ancillary analysis of the MAGNETIC.1 study. |
|---|---|
| Authors: | Dri, A.1 (AUTHOR), Foffano, L.1 (AUTHOR), Molteni, E.1 (AUTHOR), Franzoni, A.2 (AUTHOR), Lay, L.1 (AUTHOR), Cucciniello, L.1 (AUTHOR), Da Ros, L.3 (AUTHOR), Buriolla, S.4 (AUTHOR), Bolzonello, S.5 (AUTHOR), Noto, C.1 (AUTHOR), Russo, S.4 (AUTHOR), Spazzapan, S.3 (AUTHOR), Nascimbeni, E.3 (AUTHOR), Pastò, B.1 (AUTHOR), Bonotto, M.4 (AUTHOR), Minisini, A.M.M.4 (AUTHOR), Damante, G.2 (AUTHOR), Belletti, B.6 (AUTHOR), Gerratana, L.1 (AUTHOR), Puglisi, F.7 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS395-S395. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.364 |
